MBB Public Markets I LLC Makes New $299,000 Investment in Align Technology, Inc. $ALGN

Key Points

• MBB Public Markets I LLC made a new investment of $299,000 in Align Technology, acquiring 1,881 shares of the company during the first quarter.
• Align Technology reported Q2 earnings of $2.49 per share, falling short of the $2.57 estimate, with revenue also below expectations at $1.01 billion.
• Align Technology announced a stock buyback program allowing the company to repurchase $200 million in shares, indicating management's belief that the stock is undervalued.

MBB Public Markets I LLC acquired a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 1,881 shares of the medical equipment provider's stock, valued at approximately $299,000.

Other hedge funds have also modified their holdings of the company. Compagnie Lombard Odier SCmA bought a new position in shares of Align Technology during the first quarter worth about $32,000. Center for Financial Planning Inc. bought a new position in shares of Align Technology during the first quarter worth about $35,000. SVB Wealth LLC bought a new position in shares of Align Technology during the first quarter worth about $36,000. Orion Capital Management LLC bought a new position in shares of Align Technology during the fourth quarter worth about $42,000. Finally, Mather Group LLC. grew its holdings in shares of Align Technology by 375.0% during the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider's stock worth $69,000 after buying an additional 345 shares in the last quarter. 88.43% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Wells Fargo & Company decreased their price objective on Align Technology from $246.00 to $199.00 and set an "overweight" rating for the company in a report on Thursday, July 31st. Evercore ISI increased their price target on Align Technology from $200.00 to $220.00 and gave the company an "outperform" rating in a research report on Wednesday, July 9th. Mizuho set a $210.00 price target on Align Technology in a research report on Thursday, July 31st. Morgan Stanley reissued an "equal weight" rating and set a $154.00 price target (down from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Finally, Zacks Research cut Align Technology from a "hold" rating to a "strong sell" rating in a research report on Monday, September 1st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $215.00.

Align Technology Trading Down 0.4%

Shares of ALGN traded down $0.50 during mid-day trading on Monday, reaching $131.06. The company's stock had a trading volume of 1,057,487 shares, compared to its average volume of 1,230,132. Align Technology, Inc. has a 1-year low of $127.70 and a 1-year high of $262.87. The stock has a market cap of $9.50 billion, a P/E ratio of 22.10, a PEG ratio of 1.48 and a beta of 1.65. The business has a 50-day simple moving average of $160.62 and a two-hundred day simple moving average of $169.92.

Align Technology (NASDAQ:ALGN - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.57 by ($0.08). The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business's quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the previous year, the business earned $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. Research analysts anticipate that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology declared that its Board of Directors has authorized a share buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to buy up to 2% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

Insider Buying and Selling at Align Technology

In other news, CEO Joseph M. Hogan bought 7,576 shares of the stock in a transaction dated Friday, August 1st. The shares were bought at an average price of $131.49 per share, for a total transaction of $996,168.24. Following the completion of the purchase, the chief executive officer owned 184,945 shares in the company, valued at approximately $24,318,418.05. This trade represents a 4.27% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.66% of the company's stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.